Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus

被引:323
|
作者
Cui, LZ
Tominaga, E
Neoh, HM
Hiramatsu, K
机构
[1] Juntendo Univ, Fac Med, Dept Bacteriol, Bunkyo Ku, Tokyo 1138421, Japan
[2] Juntendo Univ, Fac Med, Dept Infect Control Sci, Bunkyo Ku, Tokyo 1138421, Japan
关键词
D O I
10.1128/AAC.50.3.1079-1082.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We present here findings of a strong positive correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus (VISA). This correlation is related to cell wall thickening, suggesting that, similar to the case with vancomycin resistance in VISA, the physical barrier of a thickened cell wall may contribute to daptomycin resistance in S. aureus.
引用
收藏
页码:1079 / 1082
页数:4
相关论文
共 50 条
  • [1] Vancomycin-intermediate resistance in Staphylococcus aureus
    Hiramatsu, Keiichi
    Kayayama, Yuki
    Matsuo, Miki
    Aiba, Yoshifumi
    Saito, Michie
    Hishinuma, Tomomi
    Iwamoto, Akira
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2014, 2 (04) : 213 - 224
  • [2] Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
    Howden, Benjamin P.
    Davies, John K.
    Johnson, Paul D. R.
    Stinear, Timothy P.
    Grayson, M. Lindsay
    CLINICAL MICROBIOLOGY REVIEWS, 2010, 23 (01) : 99 - +
  • [3] Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea
    Jung Wan Park
    Hyungmin Lee
    Jung Wook Kim
    Bongyoung Kim
    Scientific Reports, 9
  • [4] Characterization of Infections with Vancomycin-Intermediate Staphylococcus aureus (VISA) and Staphylococcus aureus with Reduced Vancomycin Susceptibility in South Korea
    Park, Jung Wan
    Lee, Hyungmin
    Kim, Jung Wook
    Kim, Bongyoung
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [5] An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus
    Patel, JB
    Jevitt, LA
    Hageman, J
    McDonald, LC
    Tenover, FC
    CLINICAL INFECTIOUS DISEASES, 2006, 42 (11) : 1652 - 1653
  • [6] Moenomycin-resistance is associated with vancomycin-intermediate susceptibility in Staphylococcus aureus
    Nishi, H
    Komatsuzawa, H
    Yamada, S
    Fujiwara, T
    Ohara, M
    Ohta, K
    Sugiyama, M
    Ishikawa, T
    Sugai, M
    MICROBIOLOGY AND IMMUNOLOGY, 2003, 47 (12) : 927 - 935
  • [7] Evaluation of the combination of daptomycin and nafcillin against vancomycin-intermediate Staphylococcus aureus
    Leonard, Steven N.
    Rolek, Kiri M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (03) : 644 - 647
  • [8] Vancomycin-intermediate Staphylococcus aureus in Korea
    Kim, MN
    Pai, CH
    Woo, JH
    Ryu, JS
    Hiramatsu, K
    JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (10) : 3879 - 3881
  • [9] The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus
    Appelbaum, PC
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 : 16 - 23
  • [10] Contribution of vraSR and graSR Point Mutations to Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus
    Cui, Longzhu
    Neoh, Hui-min
    Shoji, Mitsutaka
    Hiramatsu, Keiichi
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (03) : 1231 - 1234